Loading quote...
State Street SPDR S&P Biotech ETF (XBI) is an exchange-traded fund (ETF) listed on the New York Stock Exchange Arca. It pays a current dividend yield of 0.37% ($0.57 per share annually (TTM)). The most recent ex-dividend date was June 22, 2026, with payment scheduled for June 24, 2026. market capitalization is approximately $7.69B.
XBI holds 155 positions, with 13.8% of assets in its ten largest. It charges an expense ratio of 0.35%, and manages $9.96B.
| Holding | Weight |
|---|---|
| APGEAPOGEE THERAPEUTICS INC | 1.64% |
| TWSTTWIST BIOSCIENCE CORP | 1.51% |
| ORKAORUKA THERAPEUTICS INC | 1.50% |
| DNTHDIANTHUS THERAPEUTICS INC | 1.41% |
| ERASERASCA INC | 1.35% |
| KYMRKYMERA THERAPEUTICS INC | 1.30% |
| PRAXPRAXIS PRECISION MEDICINES I | 1.29% |
| RVMDREVOLUTION MEDICINES INC | 1.28% |
| SYRESPYRE THERAPEUTICS INC | 1.28% |
| REGNREGENERON PHARMACEUTICALS | 1.28% |